All Articles

Browse all articles — filter by topic, how strong the science is, or date.

Showing 553–576 of 767 in Treatments & Drugs

Apr 21, 2026globenewswire.com

Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors

generalTreatments & Drugs

Apr 21, 2026globenewswire.com

Twentyeight Health Launches First Nationwide All-in-One Virtual Clinic & Personalized Care for Women

generalTreatments & Drugs

Apr 21, 2026globenewswire.com

Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data

generalTreatments & Drugs

Apr 21, 2026globenewswire.com

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

generalTreatments & Drugs

Apr 21, 2026globenewswire.com

BudPop Delta-9 + CBN Gummies Featured in 2026 Analysis of Sleep-Focused Cannabinoid Formulations

generalTreatments & Drugs

Apr 21, 2026globenewswire.com

Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety

generalTreatments & Drugs

Apr 21, 2026sciencedaily.com

Scientists discover hidden “master switch” driving skin cancer growth and immune escape

significantTreatments & Drugs

Apr 21, 2026longevity.technology

AlzeCure completes Phase Ib study of ACD856

significantTreatments & Drugs

Apr 21, 2026sciencedaily.com

Scientists discover skincare compound that kills drug-resistant bacteria

significantTreatments & Drugs

Apr 20, 2026globenewswire.com

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

Lung Cancer Therapeutics Market to Reach $49.5 Billion by 2030, Driven by Rising Cancer Incidence and R&D Investment Surge

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026

generalTreatments & Drugs

Apr 20, 2026sciencedaily.com

This missing vitamin could stop cancer cells in their tracks

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

Pasithea Therapeutics Announces Grant of Rare Pediatric Disease Designation (RPDD) by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1)

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

generalTreatments & Drugs

Apr 20, 2026globenewswire.com

Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, A Specialty Pharmacy Focused on Complex Patient Needs

generalTreatments & Drugs

Apr 20, 2026fightaging.org

ATF5 as a Point of Tradeoff in Muscle Mass versus Muscle Quality

generalTreatments & Drugs

Apr 20, 2026longevity.technology

Omada Health study finds greater fat loss, preserved muscle

significantTreatments & Drugs

Apr 20, 2026globenewswire.com

Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology

generalTreatments & Drugs

Apr 20, 2026academic.oup.com

How does diagnostic subtype affect the quality of primary care for people with dementia? A retrospective cohort study in 1490 English general practices

significantTreatments & Drugs

Apr 19, 2026globenewswire.com

KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma

generalTreatments & Drugs